Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 420

1.

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).

Schadendorf D, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Nathan P.

Eur J Cancer. 2019 Nov;121:144-153. doi: 10.1016/j.ejca.2019.08.014. Epub 2019 Sep 30.

PMID:
31581055
2.

Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients.

Trilla-Fuertes L, Gámez-Pozo A, Díaz-Almirón M, Prado-Vázquez G, Zapater-Moros A, López-Vacas R, Nanni P, Zamora P, Espinosa E, Fresno Vara JÁ.

Future Oncol. 2019 Oct;15(30):3483-3490. doi: 10.2217/fon-2018-0698. Epub 2019 Oct 3.

PMID:
31580166
3.

Lignin: A Biopolymer from Forestry Biomass for Biocomposites and 3D Printing.

Tanase-Opedal M, Espinosa E, Rodríguez A, Chinga-Carrasco G.

Materials (Basel). 2019 Sep 16;12(18). pii: E3006. doi: 10.3390/ma12183006.

4.

microRNA and mRNA interactions in induced pluripotent stem cell reprogramming of lymphoblastoid cell lines.

Kumar S, Espinosa EC, Leandro AC, Curran JE, Blangero J.

Am J Stem Cells. 2019 Aug 15;8(2):28-37. eCollection 2019.

5.

PVA/(ligno)nanocellulose biocomposite films. Effect of residual lignin content on structural, mechanical, barrier and antioxidant properties.

Espinosa E, Bascón-Villegas I, Rosal A, Pérez-Rodríguez F, Chinga-Carrasco G, Rodríguez A.

Int J Biol Macromol. 2019 Aug 31;141:197-206. doi: 10.1016/j.ijbiomac.2019.08.262. [Epub ahead of print]

PMID:
31479671
6.

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).

Nathan P, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Schadendorf D.

Eur J Cancer. 2019 Sep;119:168-178. doi: 10.1016/j.ejca.2019.07.010. Epub 2019 Aug 21.

PMID:
31445199
7.

Effect of thermal spring water on human dendritic cell inflammatory response.

Eliasse Y, Galliano MF, Redoules D, Espinosa E.

J Inflamm Res. 2019 Jul 22;12:181-194. doi: 10.2147/JIR.S213594. eCollection 2019.

8.

Nanocellulose-Based Inks-Effect of Alginate Content on the Water Absorption of 3D Printed Constructs.

Espinosa E, Filgueira D, Rodríguez A, Chinga-Carrasco G.

Bioengineering (Basel). 2019 Jul 30;6(3). pii: E65. doi: 10.3390/bioengineering6030065.

9.

Polarization of Electron Density Databases of Transferable Multipolar Atoms.

Leduc T, Aubert E, Espinosa E, Jelsch C, Iordache C, Guillot B.

J Phys Chem A. 2019 Aug 15;123(32):7156-7170. doi: 10.1021/acs.jpca.9b05051. Epub 2019 Aug 4.

PMID:
31294565
10.

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.

Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, Zapater-Moros A, Díaz-Almirón M, Arevalillo JM, Ferrer-Gómez M, Navarro H, Maín P, Espinosa E, Pinto Á, Vara JÁF.

BMC Cancer. 2019 Jun 28;19(1):636. doi: 10.1186/s12885-019-5858-z.

11.

Melanoma proteomics suggests functional differences related to mutational status.

Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, Zapater-Moros A, Díaz-Almirón M, Fortes C, Ferrer-Gómez M, López-Vacas R, Parra Blanco V, Márquez-Rodas I, Soria A, Fresno Vara JÁ, Espinosa E.

Sci Rep. 2019 May 10;9(1):7217. doi: 10.1038/s41598-019-43512-z.

12.

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer.

Rojas L K, Trilla-Fuertes L, Gámez-Pozo A, Chiva C, Sepúlveda J, Manso L, Prado-Vázquez G, Zapater-Moros A, López-Vacas R, Ferrer-Gómez M, Mendiola C, Espinosa E, Sabidó E, Ciruelos E, Vara JÁF.

Ecancermedicalscience. 2019 Jan 15;13:891. doi: 10.3332/ecancer.2019.891. eCollection 2019.

13.

Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.

Hernández G, Ospina-Tascón GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegría L, Teboul JL, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernández P, Barahona D, Granda-Luna V, Cavalcanti AB, Bakker J; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN), Hernández G, Ospina-Tascón G, Petri Damiani L, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegría L, Teboul JL, Cecconi M, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernández P, Barahona D, Cavalcanti AB, Bakker J, Hernández G, Alegría L, Ferri G, Rodriguez N, Holger P, Soto N, Pozo M, Bakker J, Cook D, Vincent JL, Rhodes A, Kavanagh BP, Dellinger P, Rietdijk W, Carpio D, Pavéz N, Henriquez E, Bravo S, Valenzuela ED, Vera M, Dreyse J, Oviedo V, Cid MA, Larroulet M, Petruska E, Sarabia C, Gallardo D, Sanchez JE, González H, Arancibia JM, Muñoz A, Ramirez G, Aravena F, Aquevedo A, Zambrano F, Bozinovic M, Valle F, Ramirez M, Rossel V, Muñoz P, Ceballos C, Esveile C, Carmona C, Candia E, Mendoza D, Sanchez A, Ponce D, Ponce D, Lastra J, Nahuelpán B, Fasce F, Luengo C, Medel N, Cortés C, Campassi L, Rubatto P, Horna N, Furche M, Pendino JC, Bettini L, Lovesio C, González MC, Rodruguez J, Canales H, Caminos F, Galletti C, Minoldo E, Aramburu MJ, Olmos D, Nin N, Tenzi J, Quiroga C, Lacuesta P, Gaudín A, Pais R, Silvestre A, Olivera G, Rieppi G, Berrutti D, Ochoa M, Cobos P, Vintimilla F, Ramirez V, Tobar M, García F, Picoita F, Remache N, Granda V, Paredes F, Barzallo E, Garcés P, Guerrero F, Salazar S, Torres G, Tana C, Calahorrano J, Solis F, Torres P, Herrera L, Ornes A, Peréz V, Delgado G, López A, Espinosa E, Moreira J, Salcedo B, Villacres I, Suing J, Lopez M, Gomez L, Toctaquiza G, Cadena Zapata M, Orazabal MA, Pardo Espejo R, Jimenez J, Calderón A, Paredes G, Barberán JL, Moya T, Atehortua H, Sabogal R, Ortiz G, Lara A, Sanchez F, Hernán Portilla A, Dávila H, Mora JA, Calderón LE, Alvarez I, Escobar E, Bejarano A, Bustamante LA, Aldana JL.

JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071.

14.

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.

Prado-Vázquez G, Gámez-Pozo A, Trilla-Fuertes L, Arevalillo JM, Zapater-Moros A, Ferrer-Gómez M, Díaz-Almirón M, López-Vacas R, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2019 Feb 7;9(1):1538. doi: 10.1038/s41598-018-38364-y.

15.

Efficacy of rechallenge with BRAF inhibition therapy in patients with advanced BRAFV600 mutant melanoma.

Viñal D, Martinez D, Espinosa E.

Clin Transl Oncol. 2019 Aug;21(8):1061-1066. doi: 10.1007/s12094-018-02028-0. Epub 2019 Jan 3. Review.

PMID:
30607792
16.

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system.

Larkin J, Brown MP, Arance AM, Hauschild A, Queirolo P, Vecchio MD, Ascierto PA, Krajsová I, Schachter J, Neyns B, Garbe C, Sileni VC, Mandalà M, Gogas H, Espinosa E, Hospers G, Lorigan P, Nyakas M, Guminski A, Liszkay G, Rutkowski P, Miller W Jr, Donica M, Makrutzki M, Blank C.

Eur J Cancer. 2019 Jan;107:175-185. doi: 10.1016/j.ejca.2018.11.018. Epub 2018 Dec 20.

PMID:
30580112
17.

HIV Disease Progression: Overexpression of the Ectoenzyme CD38 as a Contributory Factor?

Rodríguez-Alba JC, Abrego-Peredo A, Gallardo-Hernández C, Pérez-Lara J, Santiago-Cruz W, Jiang W, Espinosa E.

Bioessays. 2019 Jan;41(1):e1800128. doi: 10.1002/bies.201800128. Epub 2018 Dec 10. Review.

PMID:
30537007
18.

Rapid and Efficient Production of Human Functional Mast Cells through a Three-Dimensional Culture of Adipose Tissue-Derived Stromal Vascular Cells.

Paupert J, Espinosa E, Cenac N, Robert V, Laharrague P, Evrard SM, Casteilla L, Lorsignol A, Cousin B.

J Immunol. 2018 Dec 15;201(12):3815-3821. doi: 10.4049/jimmunol.1701751. Epub 2018 Nov 16.

PMID:
30446570
19.

Energetic, Topological and Electric Field Analyses of Cation-Cation Nucleic Acid Interactions in Watson-Crick Disposition.

Alkorta I, Mata I, Molins E, Espinosa E.

Chemphyschem. 2019 Jan 7;20(1):148-158. doi: 10.1002/cphc.201800878. Epub 2018 Nov 29.

PMID:
30412344
20.

Expression of the growth hormone receptor isoforms and its correlation with the metabolic profile in morbidly obese subjects.

Espinosa E, Salame L, Marrero-Rodriguez D, Romero-Nieves AM, Cuenca D, Castelan-Martínez OD, Mendoza V, Ponce-Navarrete G, Salcedo M, Luque-Leòn E, Rodriguez-Gonzalez A, Mercado M.

Endocrine. 2019 Mar;63(3):573-581. doi: 10.1007/s12020-018-1794-y. Epub 2018 Oct 25.

PMID:
30361972
21.

[The importance of semiology and biochemistry in the diagnostic management of a peroxisomal biogenesis disorder].

Cote-Orozco JE, Echeverri-Pena OY, Guevara-Morales JM, Espinosa E.

Rev Neurol. 2018 Oct 16;67(8):298-302. Spanish.

22.

Temporal and Site-Specific Changes in Central Neuroimmune Factors During Rapid Weight Gain After Ovariectomy in Rats.

Curtis KS, McCracken K, Espinosa E, Ong J, Buck DJ, Davis RL.

Neurochem Res. 2018 Sep;43(9):1802-1813. doi: 10.1007/s11064-018-2596-6. Epub 2018 Jul 20.

PMID:
30030770
23.

Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases.

Espinosa E, Valitutti S, Laroche M, Laurent C, Apoil PA, Hermine O, Lavit M, Paul C, Bulai Livideanu C.

Clin Immunol. 2018 Sep;194:75-79. doi: 10.1016/j.clim.2018.07.004. Epub 2018 Jul 10.

PMID:
30004016
24.

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer.

Zapater-Moros A, Gámez-Pozo A, Prado-Vázquez G, Trilla-Fuertes L, Arevalillo JM, Díaz-Almirón M, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Oncotarget. 2018 Jun 12;9(45):27586-27594. doi: 10.18632/oncotarget.25496. eCollection 2018 Jun 12.

25.

Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR.

Sosa-Eroza E, Espinosa E, Ramírez-Rentería C, Mendoza V, Arreola R, Mercado M.

Endocrine. 2018 Aug;61(2):343-348. doi: 10.1007/s12020-018-1638-9. Epub 2018 Jun 11.

PMID:
29948930
26.

Investigation of a Thromboxane A2 Receptor-Based Vaccine for Managing Thrombogenesis.

Alshbool FZ, Karim ZA, Espinosa EVP, Lin OA, Khasawneh FT.

J Am Heart Assoc. 2018 Jun 23;7(13). pii: e009139. doi: 10.1161/JAHA.118.009139.

27.
28.

Anti-senescence compounds: A potential nutraceutical approach to healthy aging.

Gurău F, Baldoni S, Prattichizzo F, Espinosa E, Amenta F, Procopio AD, Albertini MC, Bonafè M, Olivieri F.

Ageing Res Rev. 2018 Sep;46:14-31. doi: 10.1016/j.arr.2018.05.001. Epub 2018 May 6. Review.

PMID:
29742452
29.

Molecular characterization of breast cancer cell response to metabolic drugs.

Trilla-Fuertes L, Gámez-Pozo A, Arevalillo JM, Díaz-Almirón M, Prado-Vázquez G, Zapater-Moros A, Navarro H, Aras-López R, Dapía I, López-Vacas R, Nanni P, Llorente-Armijo S, Arias P, Borobia AM, Maín P, Feliú J, Espinosa E, Fresno Vara JÁ.

Oncotarget. 2018 Jan 8;9(11):9645-9660. doi: 10.18632/oncotarget.24047. eCollection 2018 Feb 9.

30.

Quantum Crystallography: Current Developments and Future Perspectives.

Genoni A, Bučinský L, Claiser N, Contreras-García J, Dittrich B, Dominiak PM, Espinosa E, Gatti C, Giannozzi P, Gillet JM, Jayatilaka D, Macchi P, Madsen AØ, Massa L, Matta CF, Merz KM Jr, Nakashima PNH, Ott H, Ryde U, Schwarz K, Sierka M, Grabowsky S.

Chemistry. 2018 Aug 1;24(43):10881-10905. doi: 10.1002/chem.201705952. Epub 2018 Jul 13.

PMID:
29488652
31.

Coordination between replication, segregation and cell division in multi-chromosomal bacteria: lessons from Vibrio cholerae.

Espinosa E, Barre FX, Galli E.

Int Microbiol. 2017 Sep;20(3):121-129. doi: 10.2436/20.1501.01.293. Review.

32.

New roles and controls of mast cells.

Espinosa E, Valitutti S.

Curr Opin Immunol. 2018 Feb;50:39-47. doi: 10.1016/j.coi.2017.10.012. Epub 2017 Nov 13. Review.

PMID:
29144996
33.

SEOM clinical guideline for the management of malignant melanoma (2017).

Berrocal A, Arance A, Castellon VE, de la Cruz L, Espinosa E, Cao MG, Larriba JLG, Márquez-Rodas I, Soria A, Algarra SM.

Clin Transl Oncol. 2018 Jan;20(1):69-74. doi: 10.1007/s12094-017-1768-1. Epub 2017 Nov 7.

34.

Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM).

Espinosa E, Márquez-Rodas I, Soria A, Berrocal A, Manzano JL, Gonzalez-Cao M, Martin-Algarra S; Spanish Melanoma Group (GEM).

Ann Transl Med. 2017 Oct;5(19):389. doi: 10.21037/atm.2017.08.10. Review.

35.

Rapidly growing vegetables as new sources for lignocellulose nanofibre isolation: Physicochemical, thermal and rheological characterisation.

Espinosa E, Sánchez R, González Z, Domínguez-Robles J, Ferrari B, Rodríguez A.

Carbohydr Polym. 2017 Nov 1;175:27-37. doi: 10.1016/j.carbpol.2017.07.055. Epub 2017 Jul 23.

PMID:
28917866
36.

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.

Peláez-García A, Yébenes L, Berjón A, Angulo A, Zamora P, Sánchez-Méndez JI, Espinosa E, Redondo A, Heredia-Soto V, Mendiola M, Feliú J, Hardisson D.

PLoS One. 2017 Sep 8;12(9):e0183452. doi: 10.1371/journal.pone.0183452. eCollection 2017.

37.

Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Gámez-Pozo A, Trilla-Fuertes L, Berges-Soria J, Selevsek N, López-Vacas R, Díaz-Almirón M, Nanni P, Arevalillo JM, Navarro H, Grossmann J, Gayá Moreno F, Gómez Rioja R, Prado-Vázquez G, Zapater-Moros A, Main P, Feliú J, Martínez Del Prado P, Zamora P, Ciruelos E, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2017 Aug 30;7(1):10100. doi: 10.1038/s41598-017-10493-w.

38.

Effects of nicotine on homeostatic and hedonic components of food intake.

Stojakovic A, Espinosa EP, Farhad OT, Lutfy K.

J Endocrinol. 2017 Oct;235(1):R13-R31. doi: 10.1530/JOE-17-0166. Review.

39.

Toward a reverse hierarchy of halogen bonding between bromine and iodine.

Aubert E, Espinosa E, Nicolas I, Jeannin O, Fourmigué M.

Faraday Discuss. 2017 Oct 13;203:389-406. doi: 10.1039/c7fd00067g.

40.

Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.

Martín M, Chacón JI, Antón A, Plazaola A, García-Martínez E, Seguí MA, Sánchez-Rovira P, Palacios J, Calvo L, Esteban C, Espinosa E, Barnadas A, Batista N, Guerrero A, Muñoz M, Romio E, Rodríguez-Martín C, Caballero R, Casas MI, Rojo F, Carrasco E, Antolín S.

Oncologist. 2017 Nov;22(11):1301-1308. doi: 10.1634/theoncologist.2017-0052. Epub 2017 Jul 12.

41.

Isolation and characterization of lignins from wheat straw: Application as binder in lithium batteries.

Domínguez-Robles J, Sánchez R, Díaz-Carrasco P, Espinosa E, García-Domínguez MT, Rodríguez A.

Int J Biol Macromol. 2017 Nov;104(Pt A):909-918. doi: 10.1016/j.ijbiomac.2017.07.015. Epub 2017 Jul 4.

PMID:
28687383
42.

Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.

Steger GG, Dominguez A, Dobrovolskaya N, Giotta F, Tubiana-Mathieu N, Pecherstorfer M, Ardizzoia A, Blasinska-Morawiec M, Espinosa E, Villanova G.

Clin Breast Cancer. 2018 Feb;18(1):e41-e47. doi: 10.1016/j.clbc.2017.05.012. Epub 2017 Jun 27.

PMID:
28666812
43.

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.

Gámez-Pozo A, Trilla-Fuertes L, Prado-Vázquez G, Chiva C, López-Vacas R, Nanni P, Berges-Soria J, Grossmann J, Díaz-Almirón M, Ciruelos E, Sabidó E, Espinosa E, Fresno Vara JÁ.

PLoS One. 2017 Jun 8;12(6):e0178296. doi: 10.1371/journal.pone.0178296. eCollection 2017.

44.

A comparative study of the suitability of different cereal straws for lignocellulose nanofibers isolation.

Espinosa E, Sánchez R, Otero R, Domínguez-Robles J, Rodríguez A.

Int J Biol Macromol. 2017 Oct;103:990-999. doi: 10.1016/j.ijbiomac.2017.05.156. Epub 2017 May 26.

PMID:
28554790
45.

‘Mate’ Intake, Hormone-Based Risk Factors and Breast Cancer: a Case-Control Study

Ronco AL, Espinosa E, Calderon JM, Lasalvia- Galante E, De Rosa A, Sanchez G.

Asian Pac J Cancer Prev. 2017 Apr 1;18(4):941-948.

46.

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies.

Castellano D, Maroto JP, Espinosa E, Grande E, Bolós MV, Llinares J, Esteban E, González Del Alba A, Climent MA, Arranz JA, Méndez MJ, Fernández Parra E, Antón-Aparicio L, Bayona C, Gallegos I, Gallardo E, Samaniego L, García Donas J.

Expert Opin Drug Saf. 2018 Jun;17(6):573-579. doi: 10.1080/14740338.2017.1330410. Epub 2017 Aug 28.

PMID:
28535693
47.

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

Blank CU, Larkin J, Arance AM, Hauschild A, Queirolo P, Del Vecchio M, Ascierto PA, Krajsova I, Schachter J, Neyns B, Garbe C, Chiarion Sileni V, Mandalà M, Gogas H, Espinosa E, Hospers GAP, Miller WH Jr, Robson S, Makrutzki M, Antic V, Brown MP.

Eur J Cancer. 2017 Jul;79:176-184. doi: 10.1016/j.ejca.2017.04.007. Epub 2017 May 11.

PMID:
28501764
48.

Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.

Luo Z, Li Z, Martin L, Wan Z, Meissner EG, Espinosa E, Wu H, Yu X, Fu P, Julia Westerink MA, Kilby JM, Wu J, Huang L, Heath SL, Li Z, Jiang W.

J Infect Dis. 2017 Jul 1;216(1):82-91. doi: 10.1093/infdis/jix223.

49.

Direct monitoring of basophil degranulation by using avidin-based probes.

Joulia R, Mailhol C, Valitutti S, Didier A, Espinosa E.

J Allergy Clin Immunol. 2017 Oct;140(4):1159-1162.e6. doi: 10.1016/j.jaci.2017.03.030. Epub 2017 Apr 20. No abstract available.

PMID:
28433691
50.

LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.

Espinosa-de-Los-Monteros AL, Sosa-Eroza E, Espinosa E, Mendoza V, Arreola R, Mercado M.

Endocr Pract. 2017 Jul;23(7):759-767. doi: 10.4158/EP171756.OR. Epub 2017 Mar 23.

PMID:
28332874

Supplemental Content

Loading ...
Support Center